ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,211Medicare Part D Prescriptions Filled, Including Refills

Rank: 222 out of 1006

$360K Total Retail Price of All Prescriptions

Rank: 392 out of 1006

406 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 6,948 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 505 484 1 2
LISINOPRIL 354 352 2 3
SIMVASTATIN 299 277 3 1
AMLODIPINE BESYLATE 270 266 4 4
ATORVASTATIN CALCIUM 239 237 5 5
METOPROLOL TARTRATE 237 222 6 7
FUROSEMIDE 231 218 7 6
WARFARIN SODIUM 219 216 8 8
OMEPRAZOLE 203 191 9 9
METOPROLOL SUCCINATE 135 123 10 12
CARVEDILOL 128 128 11 36
ATENOLOL 128 128 11 13
MIRTAZAPINE 119 119 13 26
METFORMIN HCL 119 118 13 10
ALLOPURINOL 119 119 13 31
SERTRALINE HCL 117 106 16 19
SYNTHROID 117 111 16 42
DONEPEZIL HCL 110 110 18 17
TAMSULOSIN HCL 98 98 19 23
ZOLPIDEM TARTRATE 92 92 20 14
HYDROCHLOROTHIAZIDE 89 88 21 11
PRAVASTATIN SODIUM 71 71 22 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 66 23 38
PREDNISONE 67 67 24 33
ESCITALOPRAM OXALATE 62 62 25 27
POTASSIUM CHLORIDE 61 61 26 30
QUETIAPINE FUMARATE 61 61 26 45
ENALAPRIL MALEATE 58 58 28 83
GLIMEPIRIDE 55 55 29 50
TRAZODONE HCL 54 54 30 21
RANITIDINE HCL 51 51 31 63
DIGOXIN 51 51 31 52
CITALOPRAM HBR 51 51 31 24
LOSARTAN POTASSIUM 50 50 34 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.